Quantitative analysis for AdaptHealth Corp. Common Stock (AHCO) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (45.0) (grade C). 24 signals analyzed (19 differentiated alt-data).
AHCO stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-09 | $12.27 | $11.84 | $12.22 |
| 2026-04-21 | $12.75 | $12.11 | $12.15 |
| 2026-05-01 | $13.30 | $13.02 | $13.17 |
| 2026-05-13 | $11.24 | $10.77 | $10.81 |
| 2026-05-26 | $10.53 | $10.24 | $10.36 |
| 2026-06-05 | $10.07 | $9.76 | $9.89 |
| 2026-06-17 | $10.14 | $9.45 | $9.53 |
| 2026-06-30 | $10.47 | $9.91 | $10.42 |
| 2026-07-13 | $10.53 | $10.23 | $10.29 |
| 2026-07-23 | $10.83 | $10.37 | $10.47 |
| 2026-08-04 | $7.03 | $6.14 | $6.71 |
| 2026-08-14 | $5.91 | $5.69 | $5.81 |
How AdaptHealth Corp. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
AdaptHealth Corp. Common Stock (AHCO) scores Hold (45.0), and the composite conceals a 77-point disagreement between its dimensions. It is strongest on analyst consensus at 90 and valuation at 79, and weakest on technicals at 13. A stock can carry analyst consensus that high while technicals sits at 13; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 90 |
| valuation | 79 |
| competitive moat | 57 |
| earnings quality | 52 |
| technicals | 13 |
StoQuant analyzes 24 signals (19 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on AdaptHealth Corp. Common Stock (AHCO): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/AHCO"><img src="https://stoquant.com/badge/AHCO.svg" alt="AdaptHealth Corp. Common Stock (AHCO) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Daily Q-Score changes, insider buy clusters, and ML forecast updates for the tickers you follow. Email only, no account needed. See a sample digest.